Adaptive Biotechnologies

Adaptive Biotechnologies Corp. is a biotechnology company based in Seattle, Washington, that focuses on immune-driven medicine. Founded in 2009, the company specializes in decoding the genetics of the adaptive immune system to develop clinical products for diagnosing, treating, and monitoring diseases such as cancer, autoimmune disorders, and infectious diseases. The company’s proprietary immune-sequencing platform provides insights into T-cell and B-cell receptors, enabling the development of various products and services. Key offerings include immunoSEQ, which sequences immune receptors; clonoSEQ, a clinical assay for detecting minimal residual disease; T-Detect, a diagnostic tool for identifying diseases; and services for vaccine development and T-cell receptor screening. Adaptive collaborates with pharmaceutical companies, research institutions, and healthcare providers to advance personalized medicine and improve patient care.